spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Datwyler Launches 5/8-Inch Rigid Needle Shield, Infusion Discs

Datwyler

New solutions expand the company’s portfolio of elastomer components to meet growing and changing patient needs


Altdorf, Switzerland, 11 July 2022 — Datwyler, a leading manufacturer of elastomer components for pharmaceutical packaging, is expanding its portfolio with two new products to meet evolving patient demands. The new offerings include a 5/8 in. rigid needle shield (RNS) to address the rising need for prefilled syringes to contain vaccines for intramuscular injection, and isoprene rubber discs for infusion therapies.



Datwyler’s new 5/8 in. RNS answers the call for solutions to increasingly urgent challenges posed by the ongoing pandemic. The onset of COVID-19 has accelerated growth in demand for prefilled syringes and correlating needle shields. The prefilled syringes market is now expected to grow around 13 percent in the period 2021-2025 reaching a volume of 7.5bn units provided at global level at the end of 2025. During the same period, the 5/8 in. RNS market is expected to grow around 25 percent, reaching a volume of 1.75bn units provided at global level at the end of 2025.

“There is an expansion of global and regional immunization programs addressing viruses like COVID-19 as well as the seasonal flu and other pediatric vaccine requirements. Simultaneously, mounting safety concerns around the risk of needle stick injuries among healthcare providers are driving higher safety standards and as a result, greater interest in no-pierce, rigid plastic caps over plain rubber shields,” said Carina van Eester, Global Product Leader at Datwyler for Prefilled Syringes and Cartridges. Especially in applications that require nurses and doctors to perform many vaccinations in a short amount of time, an RNS offers more comfortable syringe handling and reduces the risk of needle sticks.

Datwyler’s 5/8 in. RNS is designed with a best-in-class rubber formulation known as FM30. FM30 enables a worldwide regulatory compliant, with a low extractable profile and an adequate gas permeability that allows ETO sterilization and facilitates controlled pull-off force, high separation force and excellent seal integrity. The design is also compatible with standard PFS and runs on standard syringe assembly lines with no necessary changes.

Additionally, Datwyler’s introduction of isoprene rubber discs will also help meet demand for the packaging of a wide range of infusion therapies. “This product is an excellent addition to Datwyler’s parenteral packaging portfolio,” said Howie Yang, Market Lead for Datwyler in China. In countries throughout Europe, the Middle East, and Asia where infusion therapies continue to be packaged in rigid plastic containers, infusion discs are highly necessary components for treatments of chronic illnesses, infectious diseases, dehydration, post-surgery treatments, and the administration of antibiotics. Available in a wide range of sizes and configurations, Datwyler’s infusion discs are manufactured at the company’s Advanced production level and in dimensions that align with ISO 15759 as well as in other customized designs. out of its newly acquired facility in Shandong, China—Yantai Xinhui Packing. The range of discs offer excellent functional properties compared to market alternatives including exceptional penetration force, resistance to fragmentation, and resealability. The discs rubber formulation also comply with international compendial requirements. The addition of infusion discs completes Datwyler’s product portfolio for IV system components, which also includes injection sites, sleeve stoppers and vascular seals for peripheral venous catheters.
phone +41 41 875 11 23
email info@datwyler.com
web https://datwyler.com/
email Militärstrasse 7 CH-6467 Schattdorf
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Cytel expansion unlocks innovative clinical development expertise for APAC biopharma sector

Waltham, MA, September 06, 2022 – Cytel Inc., a pioneer of adaptive clinical trial design and provider of advanced biometrics services, has expanded its operations into the Asia-Pacific region (APAC). This enables biotech and biopharma companies in APAC to have easier access to Cytel’s established biometrics and advanced statistical solutions. For more than 35 years, Cytel has pioneered innovative adaptive clinical trial designs and a suite of validated statistical and predictive software platforms. Cytel has also successfully supported sponsors in all aspects of innovative clinical trials, from statistical design to implementation and regulatory acceptance, helping them reduce costs, shorten timelines, and better unlock the value of their data.
More info >>


White Papers

Transforming Temperature Data Management Practices to Reduce Labor Costs and Improve Visibility and Control

Berlinger & Co AG

There are a number of temperature monitoring database options available to the biopharma supply chain professional and choosing the right one can significantly improve workflow which will reduce administrative time. This article will provide insight into practices for improving common processes through enhanced database functionality in the areas of managing data loggers by expiry date, storing and retrieving calibration certificates and acknowledging/documenting common temperature excursion events. Additionally, it describes the unique features and benefits of the Berlinger Smartview® data management system. Smartview® is a “Software as a Service” (SaaS) platform designed to efficiently and accurately manage both workflow and data in a regulatory compliant manner (21 CRF Part 11 & Annex 11). This comprehensive temperature data management system ensures reliability, accuracy, security, accessibility, and visibility to supply chain professionals, enhancing Good Distribution Practices (GDP) of temperature sensitive shipments.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement